Abstract
Aims
This study aims to establish the prevalence of aspirin, dipyridamole, clopidogrel, and warfarin use in patients undergoing cataract surgery, and to compare local anaesthetic and intraoperative complication rates between users and non-users.
Methods
The Cataract National Dataset was remotely extracted and anonymised on 55 567 operations at 12 NHS Trusts using electronic patient records (EPRs) between 2001 and 2006.
Results
This report analyses 48 862 of the 55 567 operations from the eight centres, which routinely recorded a drug history. In all, 28.1% of the 48 862 patients were taking aspirin, 5.1% warfarin, 1.9% clopidogrel, and 1.0% dipyridamole. The recording of any complication of a sharp needle or subtenon's cannula local anaesthetic block was increased in patients taking clopidogrel, 8.0% (P<0.0001) or warfarin, 6.2% (P=0.0026) vsnon-users, 4.3%, but no increase in potentially sight-threatening complications was identified. The incidence of subconjunctival haemorrhage was increased in patients taking clopidogrel, 4.4% (P<0.0001) or warfarin, 3.7% (P<0.0001) vsnon-users, 1.7%. The recording of any operative complication was increased in those taking clopidogrel, 7.3% (P=0.0002) vsnon-users, 4.4%, but the haemorrhagic operative complications of choroidal/suprachoroidal haemorrhage and hyphaema were not significantly increased. The non-haemorrhagic complication of posterior capsular rupture (PCR) was increased in those taking clopidogrel, 3.23% (P=0.0057) vsnon-users, 1.77%.
Conclusions
Clopidogrel or warfarin use was associated with a significant increase in minor complications of sharp needle and subtenon's cannula local anaesthesia but was not associated with a significant increase in potentially sight-threatening local anaesthetic or operative haemorrhagic complications.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255–1262.
Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B . Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175–179.
The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R . ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998; 316: 1337–1343.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel vs aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339.
ESPIRIT Study Group Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A . Aspirin plus dipyridamole vs aspirin alone after cerebral ischaemia of arterial origin (ESPIRIT): randomized controlled trial. Lancet 2006; 367: 1665–1673.
Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, et al., Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003; 110: 1784–1788.
Kallio H, Paloheimo M, Maunuksela EL . Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth 2000; 85: 708–711.
Assia EI, Raskin T, Kaiserman I, Rotenstreich Y, Segev F . Effect of aspirin intake on bleeding during cataract surgery. J Cataract Refract Surg 1998; 24: 1243–1246.
Carter K, Miller KM . Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg 1998; 24: 1361–1364.
Gainey SP, Robertson DM, Fay W, Ilstrup D . Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol 1989; 108: 142–146.
Hall DL, Steen Jr WH, Drummond JW, Byrd WA . Anticoagulants and cataract surgery. Ophthalmic Surg 1988; 19: 221–222.
McCormack P, Simcock PR, Tullo AB . Management of the anticoagulated patient for ophthalmic surgery. Eye 1993; 7: 749–750.
Robinson GA, Nylander A . Warfarin and cataract extraction. Br J Ophthalmol 1989; 73: 702–703.
Morris A, Elder M . Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol 2000; 28: 419–422.
The Royal College of Ophthalmologists. Cataract surgery guidelines. 2004. http://www.rcophth.ac.uk/docs/publications/published-guidelines/FinalVersionGuidelinesApril2007Updated.pdf.
Konstantatos A . Anticoagulation and cataract surgery: a review of the current literature. Anaesth Intensive Care 2001; 29: 11–18.
Leong JY, Baker RA, Shah PJ, Cherian VK, Knight JL . Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg 2005; 80: 928–933.
Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA . Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004; 78: 1536–1541.
Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ . Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129: 734–737.
Nuutinen LS, Pihlajaniemi R, Saarela E, Karkola P, Hollmen A . The effect of dipyridamole on the thrombocyte count and bleeding tendency in open-heart surgery. J Thorac Cardiovasc Surg 1977; 74: 295–298.
Davies BR . Combined aspirin and clopidogrel in cataract surgical patients: a new risk factor for ocular haemorrhage? Br J Ophthalmol 2004; 88: 1226–1227.
Kumar N, Jivan S, Thomas P, McLure H . Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006; 32: 1022–1025.
Jaycock P, Johnston RL, Taylor H, Adams M, Tole DM, Galloway P et al. The Cataract National Dataset electronic multi-centre audit of 55 567 operations: updating benchmark standards of care in the UK and internationally. EYE 2007. in press).
Service Implementation—Do Once and Share. Appendix P, Cataract National Dataset. 2006. http://www.rcophth.ac.uk/docs/college/doas/DOAS_Cataract_Final_Report_Appendix_P.xls.
El-Hindy N, Johnston RL, Jaycock P, Eke T, Braga AJ, Tole DM, et al., the UK EPR User Group. The Cataract National Dataset electronic multi-centre audit of 55 567 operations: anaesthetic techniques and complications. EYE 2007. (in press).
Narendran N, Jaycock P, Johnston RL, Taylor H, Adams M, Tole DM et al. The Cataract National Dataset electronic multi-centre audit of 55 567 operations: risk stratification for posterior capsule rupture and vitreous loss. EYE 2007. submitted).
Service Implementation—Do Once and Share. Visual Failure (Cataract) Action Team. Final Report 2006. http://www.rcophth.ac.uk/docs/college/doas/DOAS_Cataract_Action_Team_Final_Report_v1.0.DOC.
Javitt JC . Rule Britannia. Eye 2005; 19: 727–728.
Acknowledgements
This study was supported by the Cataract Do Once and Share Initiative and the EPR Users Group. Financial interest declaration: RL Johnston is a Director of Medisoft Limited.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Benzimra, J., Johnston, R., Jaycock, P. et al. The Cataract National Dataset electronic multicentre audit of 55 567 operations: antiplatelet and anticoagulant medications. Eye 23, 10–16 (2009). https://doi.org/10.1038/sj.eye.6703069
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6703069
Keywords
This article is cited by
-
Effect of direct oral anticoagulants on bleeding during and after cataract surgery
International Ophthalmology (2024)
-
The Royal College of Ophthalmologists’ National Ophthalmology Database Study of Cataract Surgery: Report 12, Risk factors for suprachoroidal haemorrhage during cataract surgery
Eye (2023)
-
Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
International Ophthalmology (2022)
-
Sub-Tenon’s anaesthesia for modern eye surgery—clinicians’ perspective, 30 years after re-introduction
Eye (2021)
-
Transient ocular surface non-perfusion during cataract phacoemulsification surgery
BMC Ophthalmology (2020)
